320 related articles for article (PubMed ID: 19712714)
21. Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer.
Jung J; Park SJ; Chung HK; Kang HW; Lee SW; Seo MH; Park HJ; Song SY; Jeong SY; Choi EK
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e77-83. PubMed ID: 22795728
[TBL] [Abstract][Full Text] [Related]
22. A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.
Su X; Gao C; Shi F; Feng X; Liu L; Qu D; Wang C
Drug Deliv; 2017 Nov; 24(1):10-19. PubMed ID: 28155336
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
24. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
26. Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
Schluep T; Gunawan P; Ma L; Jensen GS; Duringer J; Hinton S; Richter W; Hwang J
Clin Cancer Res; 2009 Jan; 15(1):181-9. PubMed ID: 19118045
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
Liu F; Feng L; Zhang L; Zhang X; Zhang N
Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199
[TBL] [Abstract][Full Text] [Related]
29. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
30. Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel.
Liu J; Zahedi P; Zeng F; Allen C
J Pharm Sci; 2008 Aug; 97(8):3274-90. PubMed ID: 18064681
[TBL] [Abstract][Full Text] [Related]
31. The antitumor effect of novel docetaxel-loaded thermosensitive micelles.
Liu B; Yang M; Li R; Ding Y; Qian X; Yu L; Jiang X
Eur J Pharm Biopharm; 2008 Jun; 69(2):527-34. PubMed ID: 18359617
[TBL] [Abstract][Full Text] [Related]
32. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Shi J; Zhang H; Wang L; Li L; Wang H; Wang Z; Li Z; Chen C; Hou L; Zhang C; Zhang Z
Biomaterials; 2013 Jan; 34(1):251-61. PubMed ID: 23069706
[TBL] [Abstract][Full Text] [Related]
33. Transarterial chemoembolization using docetaxel-loaded phytantriol cubic phase precursor for the treatment of hepatocellular carcinoma.
Han K; Wang Z; Peng X; Chen B; Wen X; Dong Y; Wu C
J Pharm Sci; 2011 Jun; 100(6):2240-7. PubMed ID: 21491445
[TBL] [Abstract][Full Text] [Related]
34. Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.
Ben Reguiga M; Bouquet C; Farinotti R; Bonhomme-Faivre L
Life Sci; 2012 Oct; 91(17-18):843-51. PubMed ID: 23047021
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
Springate CM; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
[TBL] [Abstract][Full Text] [Related]
36. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
37. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
38. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
[TBL] [Abstract][Full Text] [Related]
40. The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo.
Liu P; Chen L; Huang X
Cancer Biother Radiopharm; 2009 Feb; 24(1):91-8. PubMed ID: 19243251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
